MINIRIN SPRAY 10 micrograms per dose, solution endonasale in a spray bottle bottle, 2.5 ml
Active ingredients: Desmopressin, Desmopressin acetate trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solutionbottle, 2.5 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MINIRIN SPRAY 10 microgrammes par dose, solution endonasale en flacon pulvérisateur
- Pharmaceutical form
- solution
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) en verre brun pulvérisateur(s) avec pompe(s) doseuse(s) avec embout(s) nasal(aux) de 2,5 ml
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- diabète insipide d'origine centrale pitresso-sensible. ; JOURNAL OFFICIEL ; 01/08/93
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 1989
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62263894CIP73305504CIP133400933055042Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESMOPRESSINE (ACÉTATE DE) TRIHYDRATÉsolution | 0,1 mg · 1 ml | SA |
| DESMOPRESSINEsolution | 0,089 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.